Literature DB >> 6264993

Megakaryoblastic leukemia presenting as acute myelofibrosis -- a study of four cases with the platelet-peroxidase reaction.

B J Bain, D Catovsky, M O'Brien, H G Prentice, E Lawlor, T O Kumaran, S R McCann, E Matutes, D A Galton.   

Abstract

Acute myelofibrosis (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which bone marrow fibrosis is associated with a proliferation of immature myeloid cells. In four patients with typical AM, investigated by the platelet-peroxidase reaction at ultrastructural level, the blast cells were found to be megakaryoblasts. One patient, treated with the drug combination DAT, achieved a complete remission of 5 mo duration. This study supports the view that megakaryoblastic leukemia is the most frequent underlying cause of AM and proposes that it should be classified as a form of acute myeloid leukemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264993

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Development of acute leukaemia after idiopathic myelofibrosis.

Authors:  J M Hernández; J F San Miguel; M González; A Orfao; M C Cañizo; C Bascones; J Hernández; A López Borrasca
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14.

Authors:  M Winkelmann; C Aul; R E Scharf; A Schmitt-Gräff; F Carbonell; J L Villeval; H Grosse-Wilde; J T Fischer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-11-02

3.  Cytochemical profile of megakaryoblastic leukaemia: a study with cytochemical methods, monoclonal antibodies, and ultrastructural cytochemistry.

Authors:  M S Pombo De Oliveira; C Gregory; E Matutes; A Parreira; D Catovsky
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

4.  Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.

Authors:  G E Verhoef; C De Wolf-Peeters; A Ferrant; S Deprez; P Meeus; M Stul; P Zacheé; J J Cassiman; H Van den Berghe; M A Boogaerts
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

5.  Chronic lymphocytic leukaemia terminating in acute myelofibrosis.

Authors:  A L Lennard; S J Proctor
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

6.  Acute megakaryoblastic leukemia (acute "malignant" myelofibrosis): an unusual cause of osteosclerosis.

Authors:  S Karasick; D Karasick; J Schilling
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

7.  Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity.

Authors:  M Peeters; A Poon
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

8.  Bone marrow fibre content in acute myeloid leukaemia before and after treatment.

Authors:  A Islam; D Catovsky; J M Goldman; D A Galton
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

9.  Idiopathic acquired sideroblastic anaemia transforming to acute myelosclerosis.

Authors:  A C Bested; G Cheng; P H Pinkerton; O Kassim; J S Senn
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

Review 10.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.